Stock Events

Stock Events

Orthocell Limited 

$0.82
10
+$0+0% Monday 12:05

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
223.07M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

23FebExpected
Q2 2022
Q3 2022
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
-0.03
-0.02
-0.01
-0.01
Expected EPS
N/A
Actual EPS
-0.0198479317575

Financials

-114.02%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
9.84MRevenue
-11.22MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ORHHF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Mimedx Group
MDXG
Mkt Cap1.13B
MiMedx Group Inc specializes in regenerative biomaterials for orthopedics, similar to Orthocell's focus on regenerative medical solutions.
Precigen
PGEN
Mkt Cap1.46B
Precigen, Inc. operates in the synthetic biology field which includes regenerative medicine, overlapping with Orthocell's market.
Vericel
VCEL
Mkt Cap1.77B
Vericel Corporation produces advanced cell therapies for the treatment of patients with cartilage defects in the knee, similar to Orthocell's cartilage regeneration products.
Brainstorm Cell Therapeutics
BCLI
Mkt Cap6.74M
Brainstorm Cell Therapeutics Inc. focuses on stem cell therapies for neurodegenerative diseases, competing in the regenerative medicine space.
Mesoblast
MESO
Mkt Cap2.14B
Mesoblast Limited develops mesenchymal lineage adult stem cell therapies, competing in the regenerative medicine sector similar to Orthocell.
Fate Therapeutics
FATE
Mkt Cap155.7M
Fate Therapeutics, Inc. is involved in the development of programmed cellular immunotherapies, which is part of the broader regenerative medicine field that Orthocell operates in.

About

Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia and internationally. It offers Ortho Autologous Chondrocyte Implantation, a cartilage cell therapy for treatment of articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental applications; and Remplir, a collagen scaffold used in peripheral nerve repair. The company also develops Collagen Medical Device platform products for nerve, tendon, and ligament repair; and Tendon Cell Therapy for rotator cuff and lateral epicondyle indications. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.
Show more...
CEO
Country
AU
ISIN
AU000000OCC6

Listings

OTC Link
US
ORHHF
AU
AU
OCC.AU

0 Comments

Share your thoughts

FAQ

What is Orthocell Limited stock price today?▼
The current price of ORHHF is $0.82 USD — it has increased by +0% in the past 24 hours. Watch Orthocell Limited stock price performance more closely on the chart.
What is Orthocell Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Orthocell Limited stocks are traded under the ticker ORHHF.
What is Orthocell Limited market cap?▼
Today Orthocell Limited has the market capitalization of 223.07M
When is the next Orthocell Limited earnings date?▼
Orthocell Limited is going to release the next earnings report on August 28, 2026.
What were Orthocell Limited earnings last quarter?▼
ORHHF earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Orthocell Limited revenue for the last year?▼
Orthocell Limited revenue for the last year amounts to 9.84M USD.
What is Orthocell Limited net income for the last year?▼
ORHHF net income for the last year is -11.22M USD.
When did Orthocell Limited complete a stock split?▼
Orthocell Limited has not had any recent stock splits.